AMANDA PARTIN: Open Payments
NPI 1750890349 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$556 in 20 payments from 11 companies in 2025. Trend: 2023 $791 · 2024 $584 · 2025 $556
Food & beverage: $556
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 1 | $154 |
| Novartis Pharmaceuticals Corporation | 4 | $83 |
| AstraZeneca Pharmaceuticals LP | 3 | $65 |
| Kestra Medical Technology Services, Inc. | 1 | $44 |
| Boston Scientific Corporation | 1 | $41 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $39 |
| PFIZER INC. | 2 | $39 |
| ABIOMED | 2 | $38 |
| Lilly USA, LLC | 1 | $19 |
| Cleerly, Inc. | 1 | $18 |
Products named: AMPLATZER AMULET, LEQVIO, FARXIGA, Assure WCD, WATCHMAN, LifeVest, ELIQUIS, MOUNJARO.
Industry payments across LA — which companies pay providers there.
